Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Indocyanine Green in Endometriosis Surgery
NCT03935165Phase 2Completed
- Sponsor
- Università Cattolica del Sacro Cuore
- Start
- Jan 2016
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of indocyanine green in endometriosis, sponsored by Università Cattolica del Sacro Cuore. Primary endpoint: Localization of occult endometriotic lesion. Started Jan 2016; status: completed.
02
Drugs
indocyanine green
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT03935165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03935165.